Advisors Asset Management’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$168K	Sell	5,988 -76	-1%	-$2.49K	﹤0.01%	1181
2025 Q4	$227K	Sell	6,064 -4	-0.1%	-$132	﹤0.01%	1110
2025 Q3	$167K	Sell	6,068 -23	-0.4%	-$792	﹤0.01%	1146
2025 Q2	$192K	Buy	6,091 +3	+0%	+$97	﹤0.01%	1120
2025 Q1	$202K	Buy	6,088 +2,737	+82%	+$98.1K	﹤0.01%	1108
2024 Q4	$115K	Sell	3,351 -12,918	-79%	-$444K	﹤0.01%	1202
2024 Q3	$651K	Sell	16,269 -650	-4%	-$22.8K	0.01%	848
2024 Q2	$510K	Sell	16,919 -5,997	-26%	-$180K	0.01%	896
2024 Q1	$770K	Sell	22,916 -737	-3%	-$23.7K	0.01%	802
2023 Q4	$764K	Sell	23,653 -2,095	-8%	-$58.5K	0.02%	784
2023 Q3	$844K	Sell	25,748 -467	-2%	-$16.2K	0.02%	759
2023 Q2	$923K	Buy	26,215 +2,817	+12%	+$97.3K	0.02%	766
2023 Q1	$764K	Buy	23,398 +2,709	+13%	+$123K	0.02%	838
2022 Q4	$1.14M	Buy	20,689 +15,361	+288%	+$845K	0.02%	699
2022 Q3	$236K	Buy	5,328 +1,074	+25%	+$52.4K	0.01%	1105
2022 Q2	$207K	Buy	+4,254	New	+$192K	﹤0.01%	1157